Current Opinion in Pulmonary Medicine

Papers
(The TQCC of Current Opinion in Pulmonary Medicine is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis47
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis39
The persistent problem of persistent air-leaks: approach to management33
Thoracic empyema: aetiology, diagnosis, treatment, and prevention31
Bronchoscopic treatment of early-stage peripheral lung cancer30
Home monitoring in asthma: towards digital twins30
The role of PET in the management of sarcoidosis28
Improving care in lung cancer surgery: a review of quality measures and evolving standards27
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis24
Digital outcome measures in pulmonary clinical trials19
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?19
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients18
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?18
Implementation of digital home monitoring and management of respiratory disease17
Group 2 pulmonary hypertension: from diagnosis to treatment17
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease16
Considerations and clinical management of infections in sarcoidosis16
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?16
Lung transplant referral considerations for individuals with cystic fibrosis15
Editorial introductions15
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant15
Editorial introductions15
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice14
Asthma in pregnancy: a review of recent literature14
Casting light on the many facets of sarcoidosis14
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions14
The future of clinical trials in idiopathic pulmonary fibrosis14
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies14
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis13
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens13
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes13
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing13
Sarcoidosis and frailty: recognizing factors that foster holistic resilience13
Progress for all: addressing disparities in sarcoidosis12
Cystic fibrosis liver disease in the post-modulator era12
Digital inhalers for asthma management12
What causes cough in pulmonary fibrosis, and how should we treat it?12
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease12
Tobacco treatment in the setting of lung cancer screening12
Imaging in peripheral bronchoscopy12
Acute rejection post lung transplant12
Home monitoring of coronavirus disease 2019 patients in different phases of disease11
Editorial: Are we ready for prime time?11
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease11
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators11
Effectiveness and safety of coronavirus disease 2019 vaccines10
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort10
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease10
Novel insights in fibrotic pulmonary sarcoidosis10
Exhaled breath analysis in interstitial lung disease10
Patterns of progression in non-IPF fibrotic interstitial lung disease10
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown10
Multidisciplinary care in nonmalignant central airway obstruction9
Epigenetics and aging: relevance for sleep medicine9
Telerehabilitation in pulmonary diseases9
Infection control in cystic fibrosis: evolving perspectives and challenges9
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future9
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities9
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism9
Altered pharmacology and toxicology during ageing: implications for lung disease9
Pulmonary rehabilitation in idiopathic pulmonary fibrosis8
The changing landscape of infections in the lung transplant recipient8
The association of preexisting severe asthma with COVID-19 outcomes8
Prader–Willi syndrome: an update8
Approach to the hospitalized patient with pulmonary arterial hypertension8
Right ventricular assessment in pulmonary hypertension8
Adenotonsillectomy: the good, the bad and the unknown8
Ergonomics in bronchoscopy8
Advancements in airway stents: a comprehensive update8
Long-term safety, durability of response, cessation and switching of biologics8
Editorial: ‘What is your occupation?’: historical snippets8
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians8
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections8
Military deployment-related respiratory problems: an update8
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?8
0.12675499916077